TNXP peer analysis
Tonix Pharmaceuticals (TNXP) against its competitors: price, today's move, 1-year return and market value side by side.
TNXP and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| AVTX Avalo Therapeutics | $7.90 | -7.17% | -49.03% | $423.68M |
| ELDN Eledon Pharmaceuticals | $2.56 | -4.12% | 20.19% | $208.03M |
| ELTX Elicio | $1.63 | 1.24% | -82.34% | $46.14M |
| FATE Fate Therapeutics | $1.31 | -18.38% | 16.96% | $159.26M |
| IPHA Innate Pharma | $1.59 | 3.25% | -30.87% | $169.03M |
| MCRB Seres Therapeutics | $1.50 | -3.85% | -89.93% | $15.29M |
| MIST Milestone Pharmaceuticals | $0.66 | 0.00% | -65.33% | $82.44M |
| NKTX Nkarta | $1.39 | -6.08% | -30.85% | $99.56M |
| TNXP Tonix Pharmaceuticals | $3.87 | -5.61% | -77.92% | $75.20M |
- TNXP's peers: AVTX (Avalo Therapeutics), ELDN (Eledon Pharmaceuticals), ELTX (Elicio), FATE (Fate Therapeutics), IPHA (Innate Pharma), MCRB (Seres Therapeutics), MIST (Milestone Pharmaceuticals), NKTX (Nkarta).
Updated 2026-11-12 15:54 UTC